SlideShare a Scribd company logo
1 of 1
Download to read offline
Bacteriophage cocktails for treatment Burkholderia cenocepacia infections in a Lemna minor model
Madison Kavanaugh
Research Advisor: Dr. Christine Weingart, Ph.D.
Denison University, Granville, Ohio 43023
Burkholderia cenocepacia is an opportunistic pathogen, a pathogen that can cause
acute and chronic infections in hosts with weakened immune systems, such as patients
with cystic fibrosis (5). B. cenocepacia is specifically associated with the development of
“cepacia syndrome” in CF patients, a disease characterized by heightened
transmissibility, a high risk of developing acute respiratory disease and sepsis, and low
survivorship (2). B. cenocepacia is also highly resistant to antibiotics. Consequently,
there is a critical need for alternative strategies to treat B. cenocepacia infections and
block transmission. This study compared the ability of DCMK bacteriophages and
bacteriophage cocktails to reduce B. cenocepacia K56-2 infection in a Lemna minor
infection. All bacteriophages and bacteriophage cocktails were successful in reducing B.
cenocepacia infection. DCMK-1,2,3,4 and DCMK-2,3,4 cocktails rescued duckweed
plants with the highest survivorship. Further investigation will include testing DCMK
bacteriophages on B. cenocepacia-infected human tissue.
Burkholderia cenocepacia is developing increasing antibiotic resistance, which
presents a challenge to the treatment of cepacia syndrome in CF patients.
Bacteriophages, also known as phages, have long been envisioned as a potential
therapy for bacterial infections (2). Bacteriophages are viruses that solely infect and
replicate within bacteria. Phages have the ability to lyse bacterial cells with high
specificity and therefore allow treatment of infections without disrupting the natural host
microflora (5).
Phage cocktails are a relatively novel idea that developed after the mixed success of
monophage treatments of bacterial infections (3). Weiling et. al (2009) found a decrease
in P. aeruginosa biofilms by 99.9% with the use of phage cocktails. Kelly et al. found the
level of bacterial phage resistance to Staphylococcus phage K was 16.1%, while the
level of phage resistance to a cocktail was 2.8%. This recent phage cocktail success
has led our team to explore the effectiveness of phage cocktails with our four
bacteriophages: DCMK-1, DCMK-2, DCMK-3, and DCMK-4.
The monophage assay confirmed that our phages are capable of rescuing duckweed
plants from B. cenocepacia with a high degree of success. DCMK-4 was the most
successful phage with 87.0±6.2% post-infection duckweed survival. DCMK-2 was the
least successful with 71.7±6.5% survival. The phages all caused significantly higher
survivorship than K56-2 controls; however, they all performed with statistically similarity
(FIG 1).
In the phage cocktail rescue assay, DCMK-1,2,3,4 and DCMK-2,3,4 had an average
of 100.0±0.0% survivorship. This indicates that addition of DCMK-1 might not be
important. Additionally, DCMK-2,3 had higher survivorship than DCMK-1,2,3. This
again indicates DCMK-1 might not play a key role in cocktails. The other cocktails
ranged from 95.8±7.2% to 79.2±7.2%. The phage cocktails seem to have performed
better than the individual phages; however, most results were not significant. In fact,
two cocktails (DCMK-3,4 and DCMK-2,4) and DCMK-2 were the least effective at
reducing infection. DCMK-4 produced higher survivorship than DCMK-2,4 and DCMK-
3,4. This suggests cocktails are not a mere addition of anti-bacterial power--phage
behavior changes depending on interaction with other phages.
Overall, all phages and cocktails were successful in reducing B. cenocepacia
infection. This is a promising result for future studies in the Weingart lab and for other
researchers focused on bacteriophages as a possible therapy for infection.
Abstract Discussion
Introduction
Monophage Rescue Assay In order to test the phages’ efficacy in-vivo, 96-well plates
were filled with SHS and one sterile duckweed plant. Twenty microliters of a 100xLD50
dose (10-2
) of B. cenocepacia was added to each well and phage was added. Plates
were stored in a sterile bag and incubated for 96 hours at 30C prior to counting survivors.
Three trials were performed for each phage. Plants were deemed alive if 10% or more of
the plant remained green. Controls included K56-2 only, phage only, and SHS only
treated plants.
Cocktail Rescue Assay To determine if cocktails increased the survivorship of the
duckweed plants post-infection, 96-well plates were filled with SHS and one sterile
duckweed plant. Twenty microliters of a 100xLD50
dose (10-2
) of B. cenocepacia was
added to each well and the plants were placed were incubated for 4 hours to allow for
infection. Then various phage cocktails were added. Plates were stored in a sterile bag
and incubated for 96 hours at 30C prior to counting survivors. Three trials were
performed for each phage cocktail. Plants were deemed alive if 10% or more of the plant
remained green. Controls included K56-2 only, phage cocktail only, and SHS only treated
plants.
1. Abuladze, T. et al. “Bacteriophages Reduce Experimental Contamination of Hard Surfaces, Tomato, Spinach, Broccoli, and Ground Beef
by Escherichia coli O157:H7.” Applied and Environmental Microbiology. 74, 20 (2008): 6230-6238.
2. Carmody, L., Gill, J., Summer, E., Sajjan, U., Gonzalez, C., Young, R., & Lipuma, J. (2010). Efficacy of Bacteriophage Therapy in a Mode
of Pulmonary Infection. The Journal of Infectious Diseases, 264-271. Retrieved January 17, 2015.
3. Chan, Benjamin., Abedon, Stephen., and Catherine Loc-Carrilo. (2013) Phage cocktails and the future of phage therapy, Future
Microbiology. Retrieved January 26, 2015.
4. Drevinek, P. &E. Mahenthiralingam, Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
Clinical Microbiology and Infection, 16:7, 821-830. Retrieved January 20, 2015.
5. Ganesan, S., & Sajjan, U. (2012). Host Evasion by Burkholderia cenocepacia. Frontiers in Cellular and Infection Microbiology, 1, 1-9.
Retrieved January 20, 2015
6. Kelly, David., McAuliffe, Olivia., Ross, R.P., O’Mahony, Jim., and Coffey, Aidan. Development of a broad-host-range phage cocktail for
biocontrol, Bioengineered Bugs 2:1, 31-37. Retrieved 28 January 2015.
7. Tomat, D. et al. “Hard surfaces decontamination of enteropathogenic and Shiga toxin-producing Escherichia coli using bacteriophages.”
Food Research International. 57 (2014): 123-129..
8. Semler, Diana, Goudie, A., Finlay, W., Dennis, J. Aerosol Phage Therapy Efficacy in Burkholderia cepacia Complex Respiratory
Infections, Antimicrobial Agents and Chemotherapy, 58(7): 4005-4013. Retrieved January 21, 2015.
9. Weiling, Fu., Forster, Terri., Mayer, Oren., Curtin, John., Lehman, Susan., and Donlan, Rodney. Bacteriophage cocktail for the prevention
of biofilm formation by Pseudomonas aeruginosa on catheters in an In vitro model system, Antimicrobial Agents and Chemotherapy 54 (1):
297-404. Retrieved January 2015.
Results
Methods
The Weingart lab plans to use the duckweed infection model to test various cocktails at
different stages of infection. This will allow insight into how effective cocktails are at
saving plants after long periods of infection. Additional plans also are to test the infection
model on human tissue cultures. The duckweed model showed that DCMK phages and
cocktails significantly reduce infection by B. cenocepacia. A successful human tissue
model will be more useful in showing the future medicinal use of these phages.
TABLE 1 Duckweed survival rates for
bacteriophages DCMK-1, DCMK-2, DCMK-3
and DCMK-4.
TABLE 2 Duckweed survival rates for
bacteriophage cocktails.
Future Directions
FIG 1 Duckweed survival rates for DCMK individual
phages and cocktails. Phage controls not included.
Data points that share the same letter are not
significantly different, and were denoted through a
Tukey HSD test. Error bars indicate a ±1 SE.
I would like to thank the Department of Biology, the Gilpatrick Center for Student Research, and the
Anderson Endowment Program for funding this beginning of this project. I would also like to thank Dr.
Weingart for all her support and guidance and Devon Chosky for her humorous company and
willingness to make our overnight cultures when I forgot.
• DCMK-1, DCMK-2, DCMK-3, and
DCMK-4 rescued the duckweed
with high significance (ANOVA,
p<0.0001); however, they
performed with statistical similarity.
• DCMK-4 had the highest average
survivorship, while DCMK-2
appeared to be the least effective.
• DCMK-2 performed significantly
worse than the SHS and phage
controls, while the other phages
did not.
• All cocktails were successful in
rescuing duckweed plants from
infection when compared non-
treated controls (ANOVA, p<0.
0001).
• DCMK-1,2,3,4 and DCMK-2,3,4
performed significantly better
than DCMK-2,4 and DCMK-3,4
(p=0.0177). All other pairs
performed similarly.
• DCMK-2,4 and DCMK-3,4
performed significantly worse
than the SHS and cocktail
controls (ANOVA, p=0.0177).
• All phages and cocktails
were successful in
reducing B. cenocepacia
infection.
• DCMK-1,2,3,4 and DCMK-
2,3,4 had higher percent
survivals than all other
cocktails or phages.
• DCMK-2,3 had a higher
survival than DCMK-2.
• DCMK-3,4, DCMK-2,4 and
DCMK-2 were the only
phages or cocktails
significantly different than
the SHS controls.
References
Acknowledgements

More Related Content

What's hot

Survival of-newcastle-disease-virus-j.guan
Survival of-newcastle-disease-virus-j.guan Survival of-newcastle-disease-virus-j.guan
Survival of-newcastle-disease-virus-j.guan IIAD
 
Gene transfer in the liver using recombinant adeno-associated virus
Gene transfer in the liver using recombinant adeno-associated virusGene transfer in the liver using recombinant adeno-associated virus
Gene transfer in the liver using recombinant adeno-associated virusJonathan G. Godwin
 
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...Guy Boulianne
 
Jamboree final presentation!
Jamboree final presentation!Jamboree final presentation!
Jamboree final presentation!Waterloo iGEM
 
Marios Stylianou_Paper II_ Novel High-Throughput Screening Method for Identif...
Marios Stylianou_Paper II_ Novel High-Throughput Screening Method for Identif...Marios Stylianou_Paper II_ Novel High-Throughput Screening Method for Identif...
Marios Stylianou_Paper II_ Novel High-Throughput Screening Method for Identif...Marios Stylianou
 
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...Guy Boulianne
 
Profiling Hospital-Acquired Pathogens and Antibiotic Resistance Genes Webinar
Profiling Hospital-Acquired Pathogens and Antibiotic Resistance Genes WebinarProfiling Hospital-Acquired Pathogens and Antibiotic Resistance Genes Webinar
Profiling Hospital-Acquired Pathogens and Antibiotic Resistance Genes WebinarQIAGEN
 
Salmonellosis in poultry amr and ph impact
Salmonellosis in poultry amr and ph impactSalmonellosis in poultry amr and ph impact
Salmonellosis in poultry amr and ph impactTimothyOjodare1
 
Frequency, risk factors, and antibiogram of Acinetobacter species isolated fr...
Frequency, risk factors, and antibiogram of Acinetobacter species isolated fr...Frequency, risk factors, and antibiogram of Acinetobacter species isolated fr...
Frequency, risk factors, and antibiogram of Acinetobacter species isolated fr...Dr Muktikesh Dash, MD, PGDFM
 
The influence of reduced oxygen availability on gene expression in laboratory...
The influence of reduced oxygen availability on gene expression in laboratory...The influence of reduced oxygen availability on gene expression in laboratory...
The influence of reduced oxygen availability on gene expression in laboratory...Santhi Devasundaram
 
Development and comparison of capture enzyme linked immunosorbent assay and i...
Development and comparison of capture enzyme linked immunosorbent assay and i...Development and comparison of capture enzyme linked immunosorbent assay and i...
Development and comparison of capture enzyme linked immunosorbent assay and i...Alexander Decker
 
Dr Susan E Caldwell Publication Samples
Dr Susan E Caldwell Publication SamplesDr Susan E Caldwell Publication Samples
Dr Susan E Caldwell Publication SamplesSusan E Caldwell, PhD
 
Activation-of-human-immunodeficiency-virus-type-1-expression-by-Gardnerella-v...
Activation-of-human-immunodeficiency-virus-type-1-expression-by-Gardnerella-v...Activation-of-human-immunodeficiency-virus-type-1-expression-by-Gardnerella-v...
Activation-of-human-immunodeficiency-virus-type-1-expression-by-Gardnerella-v...Farhad B. Hashemi, PhD
 
GWAS analysis of QTL for resistance against Edwardsiella ictaluri in F2 inter...
GWAS analysis of QTL for resistance against Edwardsiella ictaluri in F2 inter...GWAS analysis of QTL for resistance against Edwardsiella ictaluri in F2 inter...
GWAS analysis of QTL for resistance against Edwardsiella ictaluri in F2 inter...Golden Helix
 
Increase in the prevalence of Clostridium difficileproducing toxin B in fecal...
Increase in the prevalence of Clostridium difficileproducing toxin B in fecal...Increase in the prevalence of Clostridium difficileproducing toxin B in fecal...
Increase in the prevalence of Clostridium difficileproducing toxin B in fecal...kridsada31
 
J. Antimicrob. Chemother.-2014-Oh-2458-69
J. Antimicrob. Chemother.-2014-Oh-2458-69J. Antimicrob. Chemother.-2014-Oh-2458-69
J. Antimicrob. Chemother.-2014-Oh-2458-69Ding Y Oh
 

What's hot (20)

Survival of-newcastle-disease-virus-j.guan
Survival of-newcastle-disease-virus-j.guan Survival of-newcastle-disease-virus-j.guan
Survival of-newcastle-disease-virus-j.guan
 
2016 Raab et al.
2016 Raab et al.2016 Raab et al.
2016 Raab et al.
 
Publication 3 - 3rd Author
Publication 3 - 3rd AuthorPublication 3 - 3rd Author
Publication 3 - 3rd Author
 
Gene transfer in the liver using recombinant adeno-associated virus
Gene transfer in the liver using recombinant adeno-associated virusGene transfer in the liver using recombinant adeno-associated virus
Gene transfer in the liver using recombinant adeno-associated virus
 
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...
 
Jamboree final presentation!
Jamboree final presentation!Jamboree final presentation!
Jamboree final presentation!
 
Marios Stylianou_Paper II_ Novel High-Throughput Screening Method for Identif...
Marios Stylianou_Paper II_ Novel High-Throughput Screening Method for Identif...Marios Stylianou_Paper II_ Novel High-Throughput Screening Method for Identif...
Marios Stylianou_Paper II_ Novel High-Throughput Screening Method for Identif...
 
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...
 
Profiling Hospital-Acquired Pathogens and Antibiotic Resistance Genes Webinar
Profiling Hospital-Acquired Pathogens and Antibiotic Resistance Genes WebinarProfiling Hospital-Acquired Pathogens and Antibiotic Resistance Genes Webinar
Profiling Hospital-Acquired Pathogens and Antibiotic Resistance Genes Webinar
 
Salmonellosis in poultry amr and ph impact
Salmonellosis in poultry amr and ph impactSalmonellosis in poultry amr and ph impact
Salmonellosis in poultry amr and ph impact
 
Resistance in gram negative organisms a need for antibiotic stewardship
Resistance in gram negative organisms a need for antibiotic stewardshipResistance in gram negative organisms a need for antibiotic stewardship
Resistance in gram negative organisms a need for antibiotic stewardship
 
Frequency, risk factors, and antibiogram of Acinetobacter species isolated fr...
Frequency, risk factors, and antibiogram of Acinetobacter species isolated fr...Frequency, risk factors, and antibiogram of Acinetobacter species isolated fr...
Frequency, risk factors, and antibiogram of Acinetobacter species isolated fr...
 
The influence of reduced oxygen availability on gene expression in laboratory...
The influence of reduced oxygen availability on gene expression in laboratory...The influence of reduced oxygen availability on gene expression in laboratory...
The influence of reduced oxygen availability on gene expression in laboratory...
 
campylobacter
campylobactercampylobacter
campylobacter
 
Development and comparison of capture enzyme linked immunosorbent assay and i...
Development and comparison of capture enzyme linked immunosorbent assay and i...Development and comparison of capture enzyme linked immunosorbent assay and i...
Development and comparison of capture enzyme linked immunosorbent assay and i...
 
Dr Susan E Caldwell Publication Samples
Dr Susan E Caldwell Publication SamplesDr Susan E Caldwell Publication Samples
Dr Susan E Caldwell Publication Samples
 
Activation-of-human-immunodeficiency-virus-type-1-expression-by-Gardnerella-v...
Activation-of-human-immunodeficiency-virus-type-1-expression-by-Gardnerella-v...Activation-of-human-immunodeficiency-virus-type-1-expression-by-Gardnerella-v...
Activation-of-human-immunodeficiency-virus-type-1-expression-by-Gardnerella-v...
 
GWAS analysis of QTL for resistance against Edwardsiella ictaluri in F2 inter...
GWAS analysis of QTL for resistance against Edwardsiella ictaluri in F2 inter...GWAS analysis of QTL for resistance against Edwardsiella ictaluri in F2 inter...
GWAS analysis of QTL for resistance against Edwardsiella ictaluri in F2 inter...
 
Increase in the prevalence of Clostridium difficileproducing toxin B in fecal...
Increase in the prevalence of Clostridium difficileproducing toxin B in fecal...Increase in the prevalence of Clostridium difficileproducing toxin B in fecal...
Increase in the prevalence of Clostridium difficileproducing toxin B in fecal...
 
J. Antimicrob. Chemother.-2014-Oh-2458-69
J. Antimicrob. Chemother.-2014-Oh-2458-69J. Antimicrob. Chemother.-2014-Oh-2458-69
J. Antimicrob. Chemother.-2014-Oh-2458-69
 

Viewers also liked

Pathema: A Bioinformatics Resource Center
Pathema: A Bioinformatics Resource CenterPathema: A Bioinformatics Resource Center
Pathema: A Bioinformatics Resource CenterPathema
 
EN_SROP_poster_to print_081011_Summer Inern_Ohio
EN_SROP_poster_to print_081011_Summer Inern_OhioEN_SROP_poster_to print_081011_Summer Inern_Ohio
EN_SROP_poster_to print_081011_Summer Inern_OhioEmily Wieber
 
Pathema Burkholderia Annotation Jamboree: Introduction to Annotation Jamboree
Pathema Burkholderia Annotation Jamboree: Introduction to Annotation JamboreePathema Burkholderia Annotation Jamboree: Introduction to Annotation Jamboree
Pathema Burkholderia Annotation Jamboree: Introduction to Annotation JamboreePathema
 
Physiological responses of_burkholderia_phytofirmans_strain_ps_jn_colonized_p...
Physiological responses of_burkholderia_phytofirmans_strain_ps_jn_colonized_p...Physiological responses of_burkholderia_phytofirmans_strain_ps_jn_colonized_p...
Physiological responses of_burkholderia_phytofirmans_strain_ps_jn_colonized_p...Andreas Theocharis
 

Viewers also liked (7)

Pathema: A Bioinformatics Resource Center
Pathema: A Bioinformatics Resource CenterPathema: A Bioinformatics Resource Center
Pathema: A Bioinformatics Resource Center
 
EN_SROP_poster_to print_081011_Summer Inern_Ohio
EN_SROP_poster_to print_081011_Summer Inern_OhioEN_SROP_poster_to print_081011_Summer Inern_Ohio
EN_SROP_poster_to print_081011_Summer Inern_Ohio
 
Pathema Burkholderia Annotation Jamboree: Introduction to Annotation Jamboree
Pathema Burkholderia Annotation Jamboree: Introduction to Annotation JamboreePathema Burkholderia Annotation Jamboree: Introduction to Annotation Jamboree
Pathema Burkholderia Annotation Jamboree: Introduction to Annotation Jamboree
 
Physiological responses of_burkholderia_phytofirmans_strain_ps_jn_colonized_p...
Physiological responses of_burkholderia_phytofirmans_strain_ps_jn_colonized_p...Physiological responses of_burkholderia_phytofirmans_strain_ps_jn_colonized_p...
Physiological responses of_burkholderia_phytofirmans_strain_ps_jn_colonized_p...
 
Janse_2013_BMCID_Burkholderia
Janse_2013_BMCID_BurkholderiaJanse_2013_BMCID_Burkholderia
Janse_2013_BMCID_Burkholderia
 
Seminar burkholderia 1
Seminar burkholderia 1Seminar burkholderia 1
Seminar burkholderia 1
 
Burkholderia spp.
Burkholderia spp.Burkholderia spp.
Burkholderia spp.
 

Similar to seniorresearchposter.pptx

International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
 
Staphylococcus epidermidis
Staphylococcus epidermidisStaphylococcus epidermidis
Staphylococcus epidermidisMicrobiology
 
Resistance pattern of cephadroxil monohydrate and ceftriaxone sodium against ...
Resistance pattern of cephadroxil monohydrate and ceftriaxone sodium against ...Resistance pattern of cephadroxil monohydrate and ceftriaxone sodium against ...
Resistance pattern of cephadroxil monohydrate and ceftriaxone sodium against ...pharmaindexing
 
Resistance pattern of cephadroxil monohydrate and ceftrixone against differen...
Resistance pattern of cephadroxil monohydrate and ceftrixone against differen...Resistance pattern of cephadroxil monohydrate and ceftrixone against differen...
Resistance pattern of cephadroxil monohydrate and ceftrixone against differen...pharmaindexing
 
Changing epidimeology by jahanzaib.pptx
Changing epidimeology by jahanzaib.pptxChanging epidimeology by jahanzaib.pptx
Changing epidimeology by jahanzaib.pptxAbdulAleemAwan1
 
Caso clinico 2, Kpc klebsiella. angelica ramirez
Caso clinico 2, Kpc klebsiella. angelica ramirezCaso clinico 2, Kpc klebsiella. angelica ramirez
Caso clinico 2, Kpc klebsiella. angelica ramirezSami Beltran
 
International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
 
recent development in culture od Cestode
recent development in culture od Cestoderecent development in culture od Cestode
recent development in culture od CestodeAbdullah Jan
 
2016 Poster Sessions Show Guide
2016 Poster Sessions Show Guide2016 Poster Sessions Show Guide
2016 Poster Sessions Show GuideNitin Dhowlaghar
 
Microbiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ FawcettMicrobiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ FawcettNicola Fawcett
 
Appl. Environ. Microbiol.-2015-Schubiger-658-65
Appl. Environ. Microbiol.-2015-Schubiger-658-65Appl. Environ. Microbiol.-2015-Schubiger-658-65
Appl. Environ. Microbiol.-2015-Schubiger-658-65Carla Schubiger
 
Water Dispersible Powder Formulation Studies
Water Dispersible Powder Formulation Studies Water Dispersible Powder Formulation Studies
Water Dispersible Powder Formulation Studies sankarshankarpillai
 
Wilde Zhou et al. Zika Inactivation paper
Wilde Zhou et al. Zika Inactivation paperWilde Zhou et al. Zika Inactivation paper
Wilde Zhou et al. Zika Inactivation paperTanya Kapes
 
Mutant prevention concentrations of some aminoglycoside antibiotics for fecal...
Mutant prevention concentrations of some aminoglycoside antibiotics for fecal...Mutant prevention concentrations of some aminoglycoside antibiotics for fecal...
Mutant prevention concentrations of some aminoglycoside antibiotics for fecal...Alexander Decker
 
Overview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
Overview of C difficile Infections - Dr Steve Brecher - November 2010 SymposiumOverview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
Overview of C difficile Infections - Dr Steve Brecher - November 2010 SymposiumEastern Pennsylvania Branch ASM
 

Similar to seniorresearchposter.pptx (20)

International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)
 
viruses-08-00300 (1)
viruses-08-00300 (1)viruses-08-00300 (1)
viruses-08-00300 (1)
 
Staphylococcus epidermidis
Staphylococcus epidermidisStaphylococcus epidermidis
Staphylococcus epidermidis
 
Ribeiro2015
Ribeiro2015Ribeiro2015
Ribeiro2015
 
vetsci-09-00406.pdf
vetsci-09-00406.pdfvetsci-09-00406.pdf
vetsci-09-00406.pdf
 
Resistance pattern of cephadroxil monohydrate and ceftriaxone sodium against ...
Resistance pattern of cephadroxil monohydrate and ceftriaxone sodium against ...Resistance pattern of cephadroxil monohydrate and ceftriaxone sodium against ...
Resistance pattern of cephadroxil monohydrate and ceftriaxone sodium against ...
 
Resistance pattern of cephadroxil monohydrate and ceftrixone against differen...
Resistance pattern of cephadroxil monohydrate and ceftrixone against differen...Resistance pattern of cephadroxil monohydrate and ceftrixone against differen...
Resistance pattern of cephadroxil monohydrate and ceftrixone against differen...
 
Changing epidimeology by jahanzaib.pptx
Changing epidimeology by jahanzaib.pptxChanging epidimeology by jahanzaib.pptx
Changing epidimeology by jahanzaib.pptx
 
Caso clinico 2, Kpc klebsiella. angelica ramirez
Caso clinico 2, Kpc klebsiella. angelica ramirezCaso clinico 2, Kpc klebsiella. angelica ramirez
Caso clinico 2, Kpc klebsiella. angelica ramirez
 
International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)
 
recent development in culture od Cestode
recent development in culture od Cestoderecent development in culture od Cestode
recent development in culture od Cestode
 
2016 Poster Sessions Show Guide
2016 Poster Sessions Show Guide2016 Poster Sessions Show Guide
2016 Poster Sessions Show Guide
 
An outbreak of burkholderia cepacia complex infections associated
An outbreak of burkholderia cepacia complex infections associatedAn outbreak of burkholderia cepacia complex infections associated
An outbreak of burkholderia cepacia complex infections associated
 
Microbiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ FawcettMicrobiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ Fawcett
 
Appl. Environ. Microbiol.-2015-Schubiger-658-65
Appl. Environ. Microbiol.-2015-Schubiger-658-65Appl. Environ. Microbiol.-2015-Schubiger-658-65
Appl. Environ. Microbiol.-2015-Schubiger-658-65
 
Water Dispersible Powder Formulation Studies
Water Dispersible Powder Formulation Studies Water Dispersible Powder Formulation Studies
Water Dispersible Powder Formulation Studies
 
Project Proposal
Project ProposalProject Proposal
Project Proposal
 
Wilde Zhou et al. Zika Inactivation paper
Wilde Zhou et al. Zika Inactivation paperWilde Zhou et al. Zika Inactivation paper
Wilde Zhou et al. Zika Inactivation paper
 
Mutant prevention concentrations of some aminoglycoside antibiotics for fecal...
Mutant prevention concentrations of some aminoglycoside antibiotics for fecal...Mutant prevention concentrations of some aminoglycoside antibiotics for fecal...
Mutant prevention concentrations of some aminoglycoside antibiotics for fecal...
 
Overview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
Overview of C difficile Infections - Dr Steve Brecher - November 2010 SymposiumOverview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
Overview of C difficile Infections - Dr Steve Brecher - November 2010 Symposium
 

seniorresearchposter.pptx

  • 1. Bacteriophage cocktails for treatment Burkholderia cenocepacia infections in a Lemna minor model Madison Kavanaugh Research Advisor: Dr. Christine Weingart, Ph.D. Denison University, Granville, Ohio 43023 Burkholderia cenocepacia is an opportunistic pathogen, a pathogen that can cause acute and chronic infections in hosts with weakened immune systems, such as patients with cystic fibrosis (5). B. cenocepacia is specifically associated with the development of “cepacia syndrome” in CF patients, a disease characterized by heightened transmissibility, a high risk of developing acute respiratory disease and sepsis, and low survivorship (2). B. cenocepacia is also highly resistant to antibiotics. Consequently, there is a critical need for alternative strategies to treat B. cenocepacia infections and block transmission. This study compared the ability of DCMK bacteriophages and bacteriophage cocktails to reduce B. cenocepacia K56-2 infection in a Lemna minor infection. All bacteriophages and bacteriophage cocktails were successful in reducing B. cenocepacia infection. DCMK-1,2,3,4 and DCMK-2,3,4 cocktails rescued duckweed plants with the highest survivorship. Further investigation will include testing DCMK bacteriophages on B. cenocepacia-infected human tissue. Burkholderia cenocepacia is developing increasing antibiotic resistance, which presents a challenge to the treatment of cepacia syndrome in CF patients. Bacteriophages, also known as phages, have long been envisioned as a potential therapy for bacterial infections (2). Bacteriophages are viruses that solely infect and replicate within bacteria. Phages have the ability to lyse bacterial cells with high specificity and therefore allow treatment of infections without disrupting the natural host microflora (5). Phage cocktails are a relatively novel idea that developed after the mixed success of monophage treatments of bacterial infections (3). Weiling et. al (2009) found a decrease in P. aeruginosa biofilms by 99.9% with the use of phage cocktails. Kelly et al. found the level of bacterial phage resistance to Staphylococcus phage K was 16.1%, while the level of phage resistance to a cocktail was 2.8%. This recent phage cocktail success has led our team to explore the effectiveness of phage cocktails with our four bacteriophages: DCMK-1, DCMK-2, DCMK-3, and DCMK-4. The monophage assay confirmed that our phages are capable of rescuing duckweed plants from B. cenocepacia with a high degree of success. DCMK-4 was the most successful phage with 87.0±6.2% post-infection duckweed survival. DCMK-2 was the least successful with 71.7±6.5% survival. The phages all caused significantly higher survivorship than K56-2 controls; however, they all performed with statistically similarity (FIG 1). In the phage cocktail rescue assay, DCMK-1,2,3,4 and DCMK-2,3,4 had an average of 100.0±0.0% survivorship. This indicates that addition of DCMK-1 might not be important. Additionally, DCMK-2,3 had higher survivorship than DCMK-1,2,3. This again indicates DCMK-1 might not play a key role in cocktails. The other cocktails ranged from 95.8±7.2% to 79.2±7.2%. The phage cocktails seem to have performed better than the individual phages; however, most results were not significant. In fact, two cocktails (DCMK-3,4 and DCMK-2,4) and DCMK-2 were the least effective at reducing infection. DCMK-4 produced higher survivorship than DCMK-2,4 and DCMK- 3,4. This suggests cocktails are not a mere addition of anti-bacterial power--phage behavior changes depending on interaction with other phages. Overall, all phages and cocktails were successful in reducing B. cenocepacia infection. This is a promising result for future studies in the Weingart lab and for other researchers focused on bacteriophages as a possible therapy for infection. Abstract Discussion Introduction Monophage Rescue Assay In order to test the phages’ efficacy in-vivo, 96-well plates were filled with SHS and one sterile duckweed plant. Twenty microliters of a 100xLD50 dose (10-2 ) of B. cenocepacia was added to each well and phage was added. Plates were stored in a sterile bag and incubated for 96 hours at 30C prior to counting survivors. Three trials were performed for each phage. Plants were deemed alive if 10% or more of the plant remained green. Controls included K56-2 only, phage only, and SHS only treated plants. Cocktail Rescue Assay To determine if cocktails increased the survivorship of the duckweed plants post-infection, 96-well plates were filled with SHS and one sterile duckweed plant. Twenty microliters of a 100xLD50 dose (10-2 ) of B. cenocepacia was added to each well and the plants were placed were incubated for 4 hours to allow for infection. Then various phage cocktails were added. Plates were stored in a sterile bag and incubated for 96 hours at 30C prior to counting survivors. Three trials were performed for each phage cocktail. Plants were deemed alive if 10% or more of the plant remained green. Controls included K56-2 only, phage cocktail only, and SHS only treated plants. 1. Abuladze, T. et al. “Bacteriophages Reduce Experimental Contamination of Hard Surfaces, Tomato, Spinach, Broccoli, and Ground Beef by Escherichia coli O157:H7.” Applied and Environmental Microbiology. 74, 20 (2008): 6230-6238. 2. Carmody, L., Gill, J., Summer, E., Sajjan, U., Gonzalez, C., Young, R., & Lipuma, J. (2010). Efficacy of Bacteriophage Therapy in a Mode of Pulmonary Infection. The Journal of Infectious Diseases, 264-271. Retrieved January 17, 2015. 3. Chan, Benjamin., Abedon, Stephen., and Catherine Loc-Carrilo. (2013) Phage cocktails and the future of phage therapy, Future Microbiology. Retrieved January 26, 2015. 4. Drevinek, P. &E. Mahenthiralingam, Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clinical Microbiology and Infection, 16:7, 821-830. Retrieved January 20, 2015. 5. Ganesan, S., & Sajjan, U. (2012). Host Evasion by Burkholderia cenocepacia. Frontiers in Cellular and Infection Microbiology, 1, 1-9. Retrieved January 20, 2015 6. Kelly, David., McAuliffe, Olivia., Ross, R.P., O’Mahony, Jim., and Coffey, Aidan. Development of a broad-host-range phage cocktail for biocontrol, Bioengineered Bugs 2:1, 31-37. Retrieved 28 January 2015. 7. Tomat, D. et al. “Hard surfaces decontamination of enteropathogenic and Shiga toxin-producing Escherichia coli using bacteriophages.” Food Research International. 57 (2014): 123-129.. 8. Semler, Diana, Goudie, A., Finlay, W., Dennis, J. Aerosol Phage Therapy Efficacy in Burkholderia cepacia Complex Respiratory Infections, Antimicrobial Agents and Chemotherapy, 58(7): 4005-4013. Retrieved January 21, 2015. 9. Weiling, Fu., Forster, Terri., Mayer, Oren., Curtin, John., Lehman, Susan., and Donlan, Rodney. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an In vitro model system, Antimicrobial Agents and Chemotherapy 54 (1): 297-404. Retrieved January 2015. Results Methods The Weingart lab plans to use the duckweed infection model to test various cocktails at different stages of infection. This will allow insight into how effective cocktails are at saving plants after long periods of infection. Additional plans also are to test the infection model on human tissue cultures. The duckweed model showed that DCMK phages and cocktails significantly reduce infection by B. cenocepacia. A successful human tissue model will be more useful in showing the future medicinal use of these phages. TABLE 1 Duckweed survival rates for bacteriophages DCMK-1, DCMK-2, DCMK-3 and DCMK-4. TABLE 2 Duckweed survival rates for bacteriophage cocktails. Future Directions FIG 1 Duckweed survival rates for DCMK individual phages and cocktails. Phage controls not included. Data points that share the same letter are not significantly different, and were denoted through a Tukey HSD test. Error bars indicate a ±1 SE. I would like to thank the Department of Biology, the Gilpatrick Center for Student Research, and the Anderson Endowment Program for funding this beginning of this project. I would also like to thank Dr. Weingart for all her support and guidance and Devon Chosky for her humorous company and willingness to make our overnight cultures when I forgot. • DCMK-1, DCMK-2, DCMK-3, and DCMK-4 rescued the duckweed with high significance (ANOVA, p<0.0001); however, they performed with statistical similarity. • DCMK-4 had the highest average survivorship, while DCMK-2 appeared to be the least effective. • DCMK-2 performed significantly worse than the SHS and phage controls, while the other phages did not. • All cocktails were successful in rescuing duckweed plants from infection when compared non- treated controls (ANOVA, p<0. 0001). • DCMK-1,2,3,4 and DCMK-2,3,4 performed significantly better than DCMK-2,4 and DCMK-3,4 (p=0.0177). All other pairs performed similarly. • DCMK-2,4 and DCMK-3,4 performed significantly worse than the SHS and cocktail controls (ANOVA, p=0.0177). • All phages and cocktails were successful in reducing B. cenocepacia infection. • DCMK-1,2,3,4 and DCMK- 2,3,4 had higher percent survivals than all other cocktails or phages. • DCMK-2,3 had a higher survival than DCMK-2. • DCMK-3,4, DCMK-2,4 and DCMK-2 were the only phages or cocktails significantly different than the SHS controls. References Acknowledgements